ARCHIVES

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

Executive Branch Should Improve Science Pay, NAS Says

July 16, 1993

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003